Description
Cefpirome Sulphate 1g + Sulbactam 500mg Injection
Farlex Critical Care presents Cefpirome Sulphate 1g + Sulbactam 500mg Injection, a powerful combination antibiotic used to treat severe bacterial infections. Cefpirome Sulphate, a fourth-generation cephalosporin, offers broad-spectrum activity, while Sulbactam, a beta-lactamase inhibitor, enhances its effectiveness against resistant bacteria.
Our Cefpirome Sulphate 1g + Sulbactam 500mg Injection is manufactured in world-class facilities adhering to rigorous quality standards, ensuring optimal safety and efficacy. As a leading Critical Care Pharma Franchise Company in India, Farlex Critical Care is committed to delivering high-quality pharmaceutical products and franchise opportunities to healthcare professionals.
Key Benefits:
- Broad-Spectrum Efficacy: Effective against a wide range of bacterial infections.
- Enhanced Potency: Sulbactam prevents the breakdown of Cefpirome by beta-lactamase enzymes.
- High-Quality Production: Manufactured in ISO and GMP certified facilities.
- Trusted Provider: Farlex Critical Care is a leading name in the critical care pharmaceutical industry.
Applications:
Cefpirome Sulphate 1g + Sulbactam 500mg Injection is used to treat severe bacterial infections such as pneumonia, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections. Always consult a healthcare professional before use.
Why Partner with Farlex Critical Care?
- We are a top Critical Care Pharma Franchise Company in India.
- We provide high-quality products and comprehensive support to our franchise partners.
- Our dedication to excellence ensures that healthcare professionals receive the best possible treatments.
For more information or to join our franchise, contact Farlex Critical Care today.
